Current Perspective on the Natural Compounds and Drug Delivery Techniques in Glioblastoma Multiforme

Tapan Behl1, Aditi Sharma2, Lalit Sharma2

  • 1Department of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India.

Cancers
|July 2, 2021
PubMed

Insights

Natural compounds offer promising glioblastoma multiforme (GBM) treatments by reducing oxidative stress and enhancing therapies. Novel drug delivery methods may improve glioblastoma treatment outcomes.

Area of Science:

  • Oncology
  • Neuroscience
  • Pharmacology

Background:

  • Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis.
  • Current treatments like temozolomide, radiotherapy, and surgery have limited efficacy due to resistance and recurrence.
  • Complex cellular signaling and redox pathway impairment contribute to GBM pathogenesis.

Purpose of the Study:

  • To review the potential of natural compounds as therapeutic agents for glioblastoma.
  • To explore novel drug delivery systems for enhanced GBM treatment.
  • To identify strategies for improving patient quality of life and survival rates for GBM patients.

Main Methods:

  • Literature review of natural compounds and their effects on glioblastoma cellular pathways.
  • Assessment of various drug delivery techniques, including nanoparticles, Gliadel wafers, and cellular carriers.
  • Analysis of mechanisms such as oxidative stress reduction, anti-proliferation, and apoptosis induction.

Main Results:

  • Natural compounds demonstrate protective effects on glial cells by mitigating oxidative stress and neuroinflammation.
  • These compounds inhibit GBM cell proliferation and induce apoptosis.
  • Drug delivery systems show potential for targeted and effective glioblastoma obliteration.

Conclusions:

  • Natural compounds represent a promising avenue for developing novel glioblastoma therapies.
  • Targeting aberrant cellular pathways with natural products can improve treatment efficacy.
  • Advanced drug delivery systems are crucial for overcoming current therapeutic limitations in GBM treatment.